RecruitingNCT05504356

Volunteers to Investigate Best Results for Ablation and Novel Therapies for Atrial Fibrillation


Sponsor

University of California, San Francisco

Enrollment

1,125 participants

Start Date

Apr 27, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

VIBRANT-AF seeks to: * Identify clinically relevant predictors of effectiveness and complications of AF ablation procedures in a prospective, US-based, multi-center, real-world longitudinal study * Assess changes in modifiable lifestyle-related exposures influence the effectiveness of AF ablation * Determine incidence and predictors of complications of AF ablation procedures Participants will connect with the Eureka Research Platform and answer a series of surveys and activities over a one-year period. They will be asked about lifestyle habits, recurrence of AFib, hospitalizations, and general feelings and emotions.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adults age 18 and older
  • Must have a smartphone device (iOS and/or Android) and cell phone number to participate on the mobile app, and will be willing to download the Eureka Research Platform mobile application
  • Must have email address to participate on the web portal (accessible on any web-connected device)
  • Undergone a catheter ablation procedure for atrial fibrillation in the week prior to recruitment, or have an ablation planned for within a week from recruitment

Exclusion Criteria2

  • Unable to consent for themselves
  • Unable to read, speak, comprehend English

Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05504356


Related Trials